Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutamate-gated chloride channel protein (GluCl or GluClR) is a pentameric ligand-gated ion channel belonging to the Cys-loop receptor superfamily, unique to invertebrates. Its activation by extracellular glutamate allows chloride ions to flow across the cell membrane, resulting in fast inhibitory synaptic transmission. The channel plays a critical role in controlling locomotion, feeding, and other behaviors in nematodes and arthropods[3][5][6][7]. GluCl is the primary molecular target for ivermectin and other broad-spectrum anthelmintics: these drugs bind allosterically, locking the channel in an open conformation, which leads to sustained hyperpolarization, paralysis, and death of the parasite[4][5][6]. Due to its absence in mammals, GluCl represents an ideal molecular target for selective antiparasitic therapies. However, widespread use of avermectins has led to an increase in resistant parasite populations, driven by mutations in GluCl subunit genes[4][7]. GluCl has no known major roles in human physiology or disease but is of significant importance for drug discovery in agriculture and tropical medicine[6][7].
Direct agonism (ivermectin/avermectins: irreversibly open channel, causing sustained chloride influx and hyperpolarization leading to paralysis of invertebrates); Competitive inhibition/blockade (picrotoxin, flufenamic acid: block channel function); Agonist/activation (glutamate: physiological activator; ibotenate: research agonist)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-gated chloride channel protein (GluCl or GluClR).